FLGT Fulgent Genetics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FLGT

Price (delayed)

$20.1

Market cap

$598.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.63

Enterprise value

$502.38M

Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high ...

Highlights
Fulgent Genetics's debt has plunged by 94% YoY and by 59% from the previous quarter
The gross profit has plunged by 72% YoY but it has grown by 13% from the previous quarter
FLGT's gross margin is down by 39% year-on-year but it is up by 12% since the previous quarter
FLGT's EPS has dropped by 167% since the previous quarter
The net income has plunged by 164% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://fulgentdiagnostics.com
Peers: OBIO OM

Key stats

What are the main financial stats of FLGT
Market
Shares outstanding
29.78M
Market cap
$598.67M
Enterprise value
$502.38M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.52
Price to sales (P/S)
2.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.74
Earnings
Revenue
$289.21M
EBIT
-$166.67M
EBITDA
-$134.12M
Free cash flow
$5.57M
Per share
EPS
-$5.63
Free cash flow per share
$0.19
Book value per share
$38.34
Revenue per share
$9.71
TBVPS
$35.93
Balance sheet
Total assets
$1.24B
Total liabilities
$102.04M
Debt
$1.18M
Equity
$1.14B
Working capital
$434.83M
Liquidity
Debt to equity
0
Current ratio
6.96
Quick ratio
6.51
Net debt/EBITDA
0.72
Margins
EBITDA margin
-46.4%
Gross margin
36.1%
Net margin
-58%
Operating margin
-67.6%
Efficiency
Return on assets
-12.6%
Return on equity
-13.6%
Return on invested capital
-17.8%
Return on capital employed
-14.3%
Return on sales
-57.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FLGT stock price

How has the Fulgent Genetics stock price performed over time
Intraday
0.35%
1 week
-1.28%
1 month
-7.07%
1 year
-30.93%
YTD
-30.47%
QTD
-7.37%

Financial performance

How have Fulgent Genetics's revenue and profit performed over time
Revenue
$289.21M
Gross profit
$104.46M
Operating income
-$195.53M
Net income
-$167.83M
Gross margin
36.1%
Net margin
-58%
The net income has plunged by 164% from the previous quarter
Fulgent Genetics's net margin has plunged by 161% from the previous quarter
Fulgent Genetics's operating income has plunged by 142% from the previous quarter
Fulgent Genetics's operating margin has plunged by 139% from the previous quarter

Growth

What is Fulgent Genetics's growth rate over time

Valuation

What is Fulgent Genetics stock price valuation
FLGT P/E details
P/E
N/A
P/B
0.52
P/S
2.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.74
FLGT's EPS has dropped by 167% since the previous quarter
The price to book (P/B) is 76% lower than the 5-year quarterly average of 2.2 and 26% lower than the last 4 quarters average of 0.7
The company's equity fell by 10% YoY and by 10% QoQ
Fulgent Genetics's revenue has shrunk by 53% YoY
FLGT's P/S is 47% below its 5-year quarterly average of 3.9 and 31% below its last 4 quarters average of 3.0

Efficiency

How efficient is Fulgent Genetics business performance
The company's return on invested capital has shrunk by 191% YoY and by 178% QoQ
The company's return on assets has shrunk by 174% QoQ
The return on equity has dropped by 172% since the previous quarter
FLGT's ROS has dropped by 170% since the previous quarter

Dividends

What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLGT.

Financial health

How did Fulgent Genetics financials performed over time
FLGT's quick ratio is down by 23% since the previous quarter
FLGT's current ratio is down by 22% since the previous quarter and by 2.4% year-on-year
Fulgent Genetics's debt is 100% less than its equity
FLGT's debt to equity has dropped by 100% year-on-year
Fulgent Genetics's debt has plunged by 94% YoY and by 59% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.